Achilles Past Earnings Performance
Past criteria checks 0/6
Achilles's earnings have been declining at an average annual rate of -56.8%, while the Chemicals industry saw earnings growing at 5.7% annually. Revenues have been declining at an average rate of 0.5% per year.
Key information
-56.8%
Earnings growth rate
-57.8%
EPS growth rate
| Chemicals Industry Growth | 6.6% |
| Revenue growth rate | -0.5% |
| Return on equity | -20.8% |
| Net Margin | -10.4% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Achilles makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 78,607 | -8,210 | 14,589 | 0 |
| 31 Dec 23 | 79,144 | -8,919 | 14,716 | 0 |
| 30 Sep 23 | 80,299 | -1,216 | 14,858 | 0 |
| 30 Jun 23 | 82,381 | -1,519 | 15,011 | 0 |
| 31 Mar 23 | 82,917 | -1,204 | 15,130 | 0 |
| 31 Dec 22 | 83,165 | 721 | 15,345 | 0 |
| 30 Sep 22 | 80,322 | 1,176 | 15,116 | 0 |
| 30 Jun 22 | 77,302 | 1,430 | 14,912 | 0 |
| 31 Mar 22 | 75,953 | 1,525 | 14,601 | 0 |
| 31 Dec 21 | 75,603 | 1,436 | 14,465 | 0 |
| 30 Sep 21 | 75,946 | 1,518 | 14,437 | 0 |
| 30 Jun 21 | 75,563 | 1,690 | 14,385 | 0 |
| 31 Mar 21 | 73,617 | 3,215 | 14,288 | 0 |
| 31 Dec 20 | 73,589 | 3,294 | 14,299 | 0 |
| 30 Sep 20 | 74,391 | 3,483 | 14,343 | 0 |
| 30 Jun 20 | 76,788 | 3,363 | 14,591 | 0 |
| 31 Mar 20 | 80,225 | 1,895 | 14,944 | 0 |
| 31 Dec 19 | 81,865 | 1,310 | 15,112 | 0 |
| 30 Sep 19 | 84,615 | 258 | 15,497 | 0 |
| 30 Jun 19 | 85,301 | 234 | 15,539 | 0 |
| 31 Mar 19 | 85,705 | 338 | 15,636 | 0 |
| 31 Dec 18 | 86,738 | 698 | 15,514 | 0 |
| 30 Sep 18 | 86,131 | 1,767 | 15,339 | 0 |
| 30 Jun 18 | 86,981 | 1,841 | 15,429 | 0 |
| 31 Mar 18 | 87,910 | 2,284 | 15,738 | 0 |
| 31 Dec 17 | 89,719 | 2,310 | 16,120 | 0 |
| 30 Sep 17 | 88,822 | 2,464 | 16,026 | 0 |
| 30 Jun 17 | 87,910 | 2,494 | 15,865 | 0 |
| 31 Mar 17 | 86,937 | 1,974 | 15,459 | 0 |
| 31 Dec 16 | 85,855 | 1,782 | 15,148 | 0 |
| 30 Sep 16 | 87,020 | 1,507 | 15,219 | 0 |
| 30 Jun 16 | 88,013 | 1,567 | 15,274 | 0 |
| 31 Mar 16 | 88,344 | 2,543 | 15,308 | 0 |
| 31 Dec 15 | 89,052 | 2,428 | 15,569 | 0 |
| 30 Sep 15 | 89,248 | 2,102 | 15,492 | 0 |
| 30 Jun 15 | 89,242 | 2,475 | 15,242 | 0 |
| 31 Mar 15 | 89,056 | 1,287 | 15,137 | 0 |
| 31 Dec 14 | 90,095 | 1,902 | 14,888 | 0 |
| 30 Sep 14 | 89,195 | 2,059 | 14,781 | 0 |
| 30 Jun 14 | 89,081 | 1,597 | 14,867 | 0 |
| 31 Mar 14 | 88,006 | 1,734 | 14,786 | 0 |
| 31 Dec 13 | 84,549 | 1,486 | 14,724 | 0 |
| 30 Sep 13 | 83,117 | 1,775 | 14,654 | 0 |
| 30 Jun 13 | 81,324 | 1,491 | 14,538 | 0 |
Quality Earnings: 5142 is currently unprofitable.
Growing Profit Margin: 5142 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 5142 is unprofitable, and losses have increased over the past 5 years at a rate of 56.8% per year.
Accelerating Growth: Unable to compare 5142's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 5142 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-1.8%).
Return on Equity
High ROE: 5142 has a negative Return on Equity (-20.76%), as it is currently unprofitable.